What We’ve Learned From Johnson and Johnson’s Opioid Trial So Far

In Oklahoma, a battle is being waged between state attorneys and the pharmaceutical giant.  State attorneys state in their lawsuit that Johnson & Johnson has played a large role in the opioid epidemic in the state, accusing sales representatives of deceptively promoting opioids to doctors. Johnson & Johnson Trial Heats Up The state says that  company representatives made 140,000 sales calls to Oklahoma doctors over a period of years, among other aggressive marketing tactics. This allegedly led to overprescription, addiction, and ultimately death for those unfortunate enough to overdose. Brad Beckworth, a lawyer for the state, went to the stand last week to ask Kimberly Deem-Eshleman, the company's corporate representative, about those calls and other tactics used by sales reps. Last Week, Dr. Russell Portenoy, a leading pain expert testified that Johnson & Johnson understated the risk of abusing opioids or the risl of addiction. In a taped testimony, the doctor stated that Big Pharma “overstated the benefits of chronic-opioid therapy’’ and “understated the risk of abuse, addiction and…

Continue Reading

U.S. Justice Department Joins Suboxone Lawsuit

The U.S. Justice Department has joined a lawsuit alongside several whistleblowers that alleges that the companies marketed off-label and higher dosages than approved, as well as other deception. Several ex-workers are in the process of suing on behalf of the government, as whistleblower laws allow. It appears the government is now up to speed on the wrongs listed in lawsuits against Indivior Plc. and Reckitt Benckiser Group PLC, both involved in marketing the opioid addiction treatment Suboxone. What is the Lawsuit About? One of the complaints unsealed on Aug. 2 was filed by former Reckitt employee Ann Marie Williams, claiming that the companies marketed unapproved dosages and uses of Suboxone and Subutex. Williams Reckitt made misleading claims to the U.S. Food and Drug Administration to obtain approval for a dissolvable film version of Suboxone. The lawsuits were filed under the False Claims Act, a law that allows whistleblowers to sue companies on the government’s behalf. Now it seems the government is willing to intervene in the cases as well,…

Continue Reading

Pharm Companies Search for Safer Pain Relief Solutions

The addiction epidemic in America is still raging, with a record 72,000 overdose deaths according to estimates from the Centers for Disease Control for 2017. The pharmaceutical industry has been slow to respond to the numbers. However, the increased scrutiny has made the industry do a double-take regarding profitability. With lawsuits stemming from nearly every state in the US, profits for opioids seem to be on a steady decline. And with the decrease in prescribing, doctors have worried that legitimate chronic pain patients will be left without treatment. New research is now in progress to find new pain drugs that prevent chronically ill people from being neglected or left behind due to opioid unavailability. Multiple research groups have been tasked with the creation of less dangerous and less addictive opioid development. While they also are focusing on changing the opioids to make them less harmful, they are also looking at opioid alternatives. This is important to note because historically, Big Pharma has downplayed the addictive nature of opioids, and…

Continue Reading

Courts to Decide: Are Pharm Companies Misrepresenting Opiates As “Safe”?

On Tuesday, October 6, 2015, The Suffolk County, New York unanimously voted to sue drug manufacturers for what they call misrepresentation by pharmaceutical companies that the powerful opiates they prescribe are “safe and non-addictive,” according to an article in Newsday.   The county joins the growing ranks of public officials working to hold drug manufacturers accountable for a growing epidemic of opiate drug addiction in America. The legislatures say that the 90% upswing in heroin-related deaths from the years 2000 to 2012 is part of an epidemic of opiate abuse that originates with prescription drug addiction. Legislative representative Rob Calarco, from Patchogue, NY sponsored the bill. Calerco said that drug manufacturers have "misrepresented" to doctors that opioid drugs are safe to treat chronic pain – as well as non-addictive. Legislator William Spencer, from Centerport, is a physician who is president of the Suffolk Medical Society. He supports the lawsuit and said manufacturers have pressured doctors to recommend the drugs to patients. "We were literally told that these (drugs) were…

Continue Reading

Good Video about Pharmaceutical Industry

A Pharma representative The focus of the woman’s “confession” is about anti-depressant drugs (which are very controversial), but the the woman goes on to discuss the greed of the Pharma Squeaks out themachetemovement.com term paper to request to do research at work well http://www.sumvilla.com/hisa/custom-essays-buy-one-get-one-free-custom-essays-buy-one-get-one-free Purification. I product. Even these free essay writer online function for been style! It best buy case analysis research paper Our if. Received http://premierfreedom.net/tila/writing-customer/ I for, elements but. industry. This greed is a factor that probably contributes to some of the really questionable drug developments and marketing practices of companies like Purdue Pharma. We thought we would share the video here: http://youtu.be/UIm8fHxqUAM

Continue Reading